Carregant...
SGLT2 Inhibitors for Type 2 Diabetes Mellitus Treatment
SGLT2 inhibitors are plausible second-line drugs that provide powerful additional A(1c)-lowering effects while inducing weight loss without hypoglycemia.
Guardat en:
| Publicat a: | Fed Pract |
|---|---|
| Autors principals: | , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Frontline Medical Communications Inc.
2015
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6375399/ https://ncbi.nlm.nih.gov/pubmed/30766102 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|